Search - tctmd.com

Displaying 21 - 40 of 133

Sort: Relevancy | Date

Presentation THT 2025

The Enduring Unmet Clinical Needs Amongst Patients Treated for Heart Failure

Presenter: Jane Wilcox

February 11, 2025

Presentation THT 2025

Atrial Shunt for Heart Failure With Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes in the REDUCE LAP-HF II Trial

Presenter: Sanjiv Shah

February 11, 2025

Presentation THT 2025

Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes After Interatrial Shunting in Heart Failure

Presenter: Stefan Anker

February 11, 2025

Presentation THT 2025

Duration of Heart Failure, Cardiac Dysfunction and Remodeling, and Response to Atrial Shunt Treatment in HFpEF and HFmrEF

Presenter: Barry Borlaug

February 11, 2025

Presentation Miami Valves 2025

Left Atrium to Coronary Sinus Shunting: Edwards’ APTURE shunt and ALT-FLOW II trial status

Presenter: Santiago Garcia

January 30, 2025

News Daily News

Top Heart Failure News of 2024

Todd Neale

December 31, 2024

Presentation TCT 2024

TCT 468: No-Implant Interatrial Shunt for Heart Failure With Preserved and Mildly-Reduced Ejection Fraction: Twelve-Month Outcomes From Multi-Center Pilot Feasibility Studies

Presenter: Brian Potter

October 28, 2024

News Daily News

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Michael O'Riordan

July 26, 2024

News Daily News

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

Michael O'Riordan

June 20, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2024

Shelley Wood

April 30, 2024

News Conference News ACC 2024

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Michael O'Riordan

April 06, 2024

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

Presentation THT 2024

Short-term Atrial Shunt Device-Induced Changes in Cardiac Structure/Function and Risk of Subsequent Heart Failure Events: Findings from the REDUCE-LAP HF II Randomized Clinical Trial

Presenter: David M. Kaye

March 05, 2024

Presentation THT Abstracts 2024

Right Ventricular Preservation with Implant-Free Interatrial Shunt

Presenter: Saibal Kar

March 05, 2024

Presentation THT 2024

One Year Outcomes of Left Atrial to Coronary Sinus Shunting for Treatment of Symptomatic Heart Failure; The ALT FLOW Early Feasibility Study One Year Results

Presenter: Firas Zahr

March 05, 2024

Presentation THT 2024

V-Wave: Final Thoughts Before the Big Reveal

Presenter: William T. Abraham

March 05, 2024

Presentation THT 2024

INTERSHUNT: Leave No Device Behind

Presenter: Saibal Kar

March 05, 2024

Presentation THT 2024

Atrial to Coronary Sinus Shunting: Early Experience With APTURE Shunt System

Presenter: Javed Butler

March 05, 2024

Presentation THT 2024

Initial Trial Results With the Alleviant Shunt System

Presenter: James E. Udelson

March 05, 2024

Presentation THT 2024

Longitudinal Echocardiographic Changes in REDUCE-LAP II

Presenter: David M. Kaye

March 05, 2024

Advertisement

The Enduring Unmet Clinical Needs Amongst Patients Treated for Heart Failure

Atrial Shunt for Heart Failure With Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes in the REDUCE LAP-HF II Trial

Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes After Interatrial Shunting in Heart Failure

Duration of Heart Failure, Cardiac Dysfunction and Remodeling, and Response to Atrial Shunt Treatment in HFpEF and HFmrEF

Left Atrium to Coronary Sinus Shunting: Edwards’ APTURE shunt and ALT-FLOW II trial status

Top Heart Failure News of 2024

TCT 468: No-Implant Interatrial Shunt for Heart Failure With Preserved and Mildly-Reduced Ejection Fraction: Twelve-Month Outcomes From Multi-Center Pilot Feasibility Studies

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

TCTMD’s Top 10 Most Popular Stories for April 2024

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Short-term Atrial Shunt Device-Induced Changes in Cardiac Structure/Function and Risk of Subsequent Heart Failure Events: Findings from the REDUCE-LAP HF II Randomized Clinical Trial

Right Ventricular Preservation with Implant-Free Interatrial Shunt

One Year Outcomes of Left Atrial to Coronary Sinus Shunting for Treatment of Symptomatic Heart Failure; The ALT FLOW Early Feasibility Study One Year Results

V-Wave: Final Thoughts Before the Big Reveal

INTERSHUNT: Leave No Device Behind

Atrial to Coronary Sinus Shunting: Early Experience With APTURE Shunt System

Initial Trial Results With the Alleviant Shunt System

Longitudinal Echocardiographic Changes in REDUCE-LAP II

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content